Stoke Therapeutics annual revenue
2022
2023
2024
2025
Stoke Therapeutics reported $184.4M in revenue for fiscal 2025, an increase of 404.50% from the previous fiscal year.
View full Stoke Therapeutics company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $184.4M | $147.9M | +404.50% |
| 2024 | 2024-12-31 | $36.6M | $27.8M | +316.34% |
| 2023 | 2023-12-31 | $8.8M | −$3.6M | −29.22% |
| 2022 | 2022-12-31 | $12.4M | — | — |
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Stoke Therapeutics filings at SEC.gov ↗